Gregg Wesolowski

6.1k total citations · 3 hit papers
49 papers, 4.5k citations indexed

About

Gregg Wesolowski is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Gregg Wesolowski has authored 49 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 30 papers in Oncology and 15 papers in Immunology and Allergy. Recurrent topics in Gregg Wesolowski's work include Bone Metabolism and Diseases (32 papers), Bone health and treatments (25 papers) and Cell Adhesion Molecules Research (15 papers). Gregg Wesolowski is often cited by papers focused on Bone Metabolism and Diseases (32 papers), Bone health and treatments (25 papers) and Cell Adhesion Molecules Research (15 papers). Gregg Wesolowski collaborates with scholars based in United States, Canada and Australia. Gregg Wesolowski's co-authors include Gideon A. Rodan, Sevgi B. Rodan, Le T. Duong, Maureen Pickarski, Tadashi Hayami, John Fisher, A A Reszka, Ya Zhuo, Mark A. Thiede and Helmut Glantschnig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Gregg Wesolowski

49 papers receiving 4.4k citations

Hit Papers

Alendronate mechanism of ... 1987 2026 2000 2013 1999 2005 1987 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregg Wesolowski United States 29 2.3k 1.7k 1.4k 874 605 49 4.5k
Ian E. James United States 30 2.7k 1.2× 1.3k 0.8× 1.3k 0.9× 546 0.6× 502 0.8× 53 4.4k
Françoise Rédiní France 48 4.1k 1.8× 3.0k 1.8× 1.5k 1.1× 714 0.8× 674 1.1× 181 7.9k
Takuhiko Akatsu Japan 32 4.5k 2.0× 3.4k 2.0× 932 0.7× 1.1k 1.2× 483 0.8× 54 6.3k
Sevgi B. Rodan United States 39 3.1k 1.4× 1.9k 1.1× 658 0.5× 513 0.6× 275 0.5× 72 5.1k
Noriyoshi Kurihara United States 37 2.4k 1.0× 2.2k 1.3× 664 0.5× 580 0.7× 225 0.4× 106 4.3k
Gabriel Mbalaviele United States 35 2.7k 1.2× 816 0.5× 664 0.5× 287 0.3× 392 0.6× 78 4.2k
Gilbert Vaes Belgium 34 2.0k 0.9× 1.3k 0.8× 1.2k 0.9× 352 0.4× 361 0.6× 81 4.5k
Fraser P. Coxon United Kingdom 35 3.5k 1.5× 5.7k 3.4× 831 0.6× 2.9k 3.3× 663 1.1× 68 8.4k
Francis Y. Lee United States 39 2.4k 1.0× 1.7k 1.0× 1.9k 1.4× 121 0.1× 665 1.1× 103 7.4k
Carl R. Flannery United States 40 1.4k 0.6× 714 0.4× 3.9k 2.9× 521 0.6× 1.3k 2.1× 76 6.2k

Countries citing papers authored by Gregg Wesolowski

Since Specialization
Citations

This map shows the geographic impact of Gregg Wesolowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg Wesolowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg Wesolowski more than expected).

Fields of papers citing papers by Gregg Wesolowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregg Wesolowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg Wesolowski. The network helps show where Gregg Wesolowski may publish in the future.

Co-authorship network of co-authors of Gregg Wesolowski

This figure shows the co-authorship network connecting the top 25 collaborators of Gregg Wesolowski. A scholar is included among the top collaborators of Gregg Wesolowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg Wesolowski. Gregg Wesolowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Bennett, Bin Luo, Gregg Wesolowski, et al.. (2017). Applicability of in vitro-in vivo translation of cathepsin K inhibition from animal species to human with the use of free-drug hypothesis. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(4). 435–441. 9 indexed citations
2.
Hayami, Tadashi, Ya Zhuo, Gregg Wesolowski, Maureen Pickarski, & Le T. Duong. (2012). Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone. 50(6). 1250–1259. 110 indexed citations
3.
Leung, Patrick P.S., Maureen Pickarski, Gregg Wesolowski, & Le T. Duong. (2008). P6. Anti-resorptive and potential anti-invasion effects of a cathepsin K inhibitor in the treatment of breast cancer-induced bone metastasis. Cancer Treatment Reviews. 34. 14–14. 1 indexed citations
4.
Watters, James, Chun Cheng, Maureen Pickarski, et al.. (2007). Inverse relationship between matrix remodeling and lipid metabolism during osteoarthritis progression in the STR/ORT mouse. Arthritis & Rheumatism. 56(9). 2999–3009. 30 indexed citations
5.
Li, Chun Sing, Denis Deschênes, Sylvie Desmarais, et al.. (2006). Identification of a potent and selective non-basic cathepsin K inhibitor. Bioorganic & Medicinal Chemistry Letters. 16(7). 1985–1989. 67 indexed citations
6.
Setti, Eduardo L., Shankar Venkatraman, James T. Palmer, et al.. (2006). Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 16(16). 4296–4299. 8 indexed citations
7.
Elsegood, Caryn L., Ya Zhuo, Gregg Wesolowski, et al.. (2006). M-CSF induces the stable interaction of cFms with αVβ3 integrin in osteoclasts. The International Journal of Biochemistry & Cell Biology. 38(9). 1518–1529. 20 indexed citations
8.
Palmer, James T., et al.. (2006). Keto‐1,3,4‐oxadiazoles as Cathepsin K Inhibitors.. ChemInform. 37(36). 1 indexed citations
9.
Hayami, Tadashi, Maureen Pickarski, Ya Zhuo, et al.. (2005). Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone. 38(2). 234–243. 535 indexed citations breakdown →
10.
Hayami, Tadashi, Maureen Pickarski, Gregg Wesolowski, et al.. (2004). The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis & Rheumatism. 50(4). 1193–1206. 464 indexed citations
11.
Falgueyret, Jean‐Pierre, W. Cameron Black, Wanda Cromlish, et al.. (2004). An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells. Analytical Biochemistry. 335(2). 218–227. 45 indexed citations
12.
Luegmayr, Eva, Helmut Glantschnig, Gregg Wesolowski, et al.. (2004). Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death and Differentiation. 11(S1). S108–S118. 115 indexed citations
13.
Lafage–Proust, Marie-Hélène, Gregg Wesolowski, Matthias Ernst, Gideon A. Rodan, & Sevgi B. Rodan. (1999). Retinoic acid effects on an SV-40 large T antigen immortalized adult rat bone cell line. Journal of Cellular Physiology. 179(3). 267–275. 5 indexed citations
14.
Lakkakorpi, Päivi T., Gregg Wesolowski, Zoran Zimolo, Gideon A. Rodan, & Sevgi B. Rodan. (1997). Phosphatidylinositol 3-Kinase Association with the Osteoclast Cytoskeleton, and Its Involvement in Osteoclast Attachment and Spreading. Experimental Cell Research. 237(2). 296–306. 67 indexed citations
15.
Schmidt, A., Evan E. Opas, Gregg Wesolowski, et al.. (1995). Alendronate inhibition of protein tyrosine phosphatase activity. Bone. 17(6). 604–604. 8 indexed citations
16.
Zimolo, Zoran, Gregg Wesolowski, & Gideon A. Rodan. (1995). Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.. Journal of Clinical Investigation. 96(5). 2277–2283. 91 indexed citations
17.
Rodan, Sevgi B., Gregg Wesolowski, Douglas J. Hilton, Nicos A. Nicola, & Gideon A. Rodan. (1990). Leukemia Inhibitory Factor Binds with High Affinity to Preosteoblastic RCT-1 Cells and Potentiates the Retinoic Acid Induction of Alkaline Phosphatase. Endocrinology. 127(4). 1602–1608. 46 indexed citations
18.
Rodan, Sevgi B., et al.. (1989). Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: stimulation by phorbol esters and epidermal growth factor. Journal of Endocrinology. 122(1). 219–NP. 100 indexed citations
19.
Rodan, Sevgi B., Masaki Noda, Gregg Wesolowski, Michael Rosenblatt, & Gideon A. Rodan. (1988). Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.. Journal of Clinical Investigation. 81(3). 924–927. 60 indexed citations
20.
Rodan, Sevgi B., Gregg Wesolowski, Kenneth A. Thomas, & Gideon A. Rodan. (1987). Growth Stimulation of Rat Calvaria Osteoblastic Cells by Acidic Fibroblast Growth Factor. Endocrinology. 121(6). 1917–1923. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026